Noan (Diazepam)

Diazepam, the active ingredient in Noan, is a benzodiazepine presented as an injectable solution for intramuscular and intravenous use. It treats anxiety disorders, seizure emergencies, muscle spasm, provides procedural sedation and assists in alcohol withdrawal management.

GNH USA supplies Noan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diazepam is a benzodiazepine that modulates GABA‑mediated neurotransmission and is used in several acute and chronic conditions.

- Anxiety disorders: reduces excessive anxiety and tension. - Status epilepticus: terminates ongoing seizures. - Muscle spasm: relaxes skeletal muscle hyperactivity. - Sedation before medical procedures: provides short‑acting sedation for diagnostic or minor surgical procedures. - Alcohol withdrawal syndrome: alleviates withdrawal symptoms and prevents complications.

Diazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or lethargic. - Fatigue: reduced energy and increased tiredness. - Dizziness: sensation of light‑headedness or unsteadiness. - Muscle weakness: decreased muscle strength, especially in the limbs. - Ataxia: impaired coordination and balance.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, potentially life‑threatening. - Severe hypotension: marked drop in blood pressure. - Paradoxical reactions: increased agitation, aggression or anxiety. - Dependence and withdrawal syndrome: risk of physical dependence with abrupt discontinuation. - Hepatotoxicity: rare liver injury manifested by elevated enzymes.

When using Noan, several safety considerations should be observed.

- Pregnancy: Category D – use only if benefits outweigh potential fetal risks. - Elderly patients: increased sensitivity; consider lower initial doses. - History of substance abuse: heightened risk of dependence; monitor closely. - Concurrent CNS depressants: may enhance sedation and respiratory depression. - Renal or hepatic impairment: may require dose adjustment due to altered metabolism. - Store at ambient temperature: keep in original container, protect from light and moisture.

Diazepam can interact with various medicines, requiring careful management.

Major Interactions (Avoid): - Opioids: additive respiratory depression. - Barbiturates: increased sedation and risk of coma. - Alcohol: profound CNS depression. - Antifungals (ketoconazole, itraconazole): increase diazepam plasma levels. - CYP3A4 inhibitors (e.g., erythromycin): raise diazepam concentrations.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase sedation. - Antihistamines: additive drowsiness. - CYP2C19 inhibitors (fluoxetine): modest increase in diazepam levels.